| scholarly article | Q13442814 |
| P50 | author | Javier Martin | Q55089349 |
| P2093 | author name string | J Llorca | |
| C Gonzalez-Juanatey | |||
| M A Gonzalez-Gay | |||
| C Garcia-Porrua | |||
| A Sanchez-Andrade | |||
| J M De Matias | |||
| P433 | issue | 1 | |
| P921 | main subject | patient | Q181600 |
| rheumatoid arthritis | Q187255 | ||
| insulin resistance | Q1053470 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 83-86 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Clinical and Experimental Rheumatology | Q15759225 |
| P1476 | title | Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. | |
| P478 | volume | 24 |
| Q36434758 | A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1 |
| Q33654451 | Abnormal Glucose Metabolism in Rheumatoid Arthritis |
| Q36979754 | Adipocytokines and the metabolic complications of obesity |
| Q30357655 | Adipocytokines in obesity and metabolic disease. |
| Q29620456 | Adipokines in inflammation and metabolic disease |
| Q36920864 | Adipokines mediate inflammation and insulin resistance |
| Q37686803 | Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis. |
| Q64994155 | Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes. |
| Q33304235 | Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis |
| Q50067550 | Anti-TNF-α antibody alleviates insulin resistance in rats with sepsis-induced stress hyperglycemia |
| Q33740024 | Anti-inflammatory and anti-insulin resistance activities of aqueous extract from Anoectochilus burmannicus |
| Q36246116 | Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance |
| Q36633289 | Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. |
| Q33650548 | Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients |
| Q52632609 | Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis. |
| Q34488816 | Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q38260198 | Cardiovascular risk and the use of biologic agents in rheumatoid arthritis |
| Q34699554 | Chronic TNF-α Neutralization Does Not Improve Insulin Resistance or Endothelial Function in “Healthy” Men with Metabolic Syndrome |
| Q45396175 | Development of diabetic nephropathy in nude mice |
| Q45973867 | Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients? |
| Q35384250 | Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome |
| Q26825588 | Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis |
| Q80657531 | Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis |
| Q54943957 | Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study. |
| Q46301149 | Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study. |
| Q91921361 | Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes |
| Q34886162 | Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci |
| Q91698437 | Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression |
| Q26753047 | Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics |
| Q42735592 | Hypoglycaemia after initiation of treatment with etanercept in a patient with type 2 diabetes mellitus |
| Q37261617 | Immune mechanisms in atherosclerosis, especially in diabetes type 2 |
| Q79610823 | Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis |
| Q36429729 | Increased toll-like receptor 2 expression in peptidoglycan-treated blood monocytes is associated with insulin resistance in patients with nondiabetic rheumatoid arthritis |
| Q42682599 | Incretins in patients with rheumatoid arthritis |
| Q22241893 | Inflammation and insulin resistance |
| Q35864675 | Inflammation as a Link between Obesity and Metabolic Syndrome |
| Q37174503 | Inflammation during obesity is not all bad: evidence from animal and human studies |
| Q37371379 | Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms |
| Q51152425 | Inflammation-related cardiovascular morbidity : Pathophysiology and therapy |
| Q59807010 | Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases |
| Q35151595 | Inflammatory concepts of obesity |
| Q84139204 | Inflammatory markers and bariatric surgery: a meta-analysis |
| Q46598130 | Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients |
| Q34597334 | Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases |
| Q37088215 | Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetes |
| Q35106076 | Mast cells and metabolic syndrome |
| Q38271745 | Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy |
| Q26822038 | Metabolic syndrome in rheumatoid arthritis |
| Q36294297 | Molecular targets related to inflammation and insulin resistance and potential interventions |
| Q39779359 | Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. |
| Q37130144 | Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? |
| Q37200269 | Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms |
| Q35860158 | Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients |
| Q38858035 | Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases |
| Q37540440 | Psoriasis comorbidities: complications and benefits of immunobiological treatment |
| Q95643265 | Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies |
| Q37689740 | Response to 'Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis'. |
| Q35092979 | Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'. |
| Q37140079 | Rheumatoid arthritis and cardiovascular disease |
| Q38236740 | Rheumatoid arthritis and metabolic syndrome |
| Q87370747 | Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA |
| Q34348857 | Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis |
| Q34023205 | Role of T cells in malnutrition and obesity |
| Q49850396 | Role of innate and adaptive immunity in obesity-associated metabolic disease |
| Q35840769 | Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study |
| Q36940636 | Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus |
| Q89455174 | TL1A regulates adipose-resident innate lymphoid immune responses and enables diet-induced obesity in mice |
| Q34571799 | TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome |
| Q38214020 | Targeting inflammation in the treatment of type 2 diabetes: time to start |
| Q36054715 | The Anti-Inflammatory Effect of Prunus yedoensis Bark Extract on Adipose Tissue in Diet-Induced Obese Mice |
| Q64091915 | The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives |
| Q37623164 | The acute effects of low-dose TNF-α on glucose metabolism and β-cell function in humans |
| Q36673550 | The vascular endothelium in diabetes--a therapeutic target? |
| Q36863273 | Therapeutic Targets for Management of Periodontitis and Diabetes |
| Q47121974 | Therapeutic Targets for Management of Periodontitis and Diabetes |
| Q50233845 | Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk |
| Q36464352 | Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis |
| Q50154733 | Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease |
| Q40132752 | Tumor Necrosis Factor-alpha- and interleukin-1-induced cellular responses: coupling proteomic and genomic information |
| Q29617184 | Type 2 diabetes as an inflammatory disease |
| Q35106315 | Vascular biology of metabolic syndrome |
| Q37630351 | Vascular effects of biologic agents in RA and spondyloarthropathies |
| Q35954625 | What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. |
Search more.